Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kraposhina (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Demko (Krasnoyarsk (Krasnoyarsk), Russian Federation), N. Gordeeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Soloveva (Krasnoyarsk (Krasnoyarsk), Russian Federation), M. Mamaeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), E. Sobko (Krasnoyarsk (Krasnoyarsk), Russian Federation). Results of vaccination against pneumococcal infection in patients with chronic heart failure. 1771

Member's Comments

No comment yet.

Related content which might interest you: Results of vaccination against pneumococcal infection in patients with chronic lung diseases Source: International Congress 2019 – Airway infection in COPD Year: 2019 Effects of pneumococcal vaccine in patients with chronic respiratory disease Source: Eur Respir Rev 2008; 17: 43-45 Year: 2008 Effects of pneumococcal vaccine in patients with chronic respiratory disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Pneumococcal vaccination in chronic respiratory patients – a cohort study Source: International Congress 2019 – Airway infection in COPD Year: 2019 Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006 Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 Effectiveness of 23-valent pneumococcal polysaccharide vaccine in preventing lower respiratory tract infections complicating chronic respiratory failure Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012